New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor ...
Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases -WAYNE, Pa., Feb. 12, 2025 ...
Aclaris Therapeutics announces publication describing properties of ATI-2138
Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...